GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 49 filers reported holding GENERATION BIO CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,960,209 | -32.6% | 8,432,773 | -2.2% | 0.00% | -25.0% |
Q2 2023 | $47,424,119 | -38.4% | 8,622,567 | -51.8% | 0.00% | 0.0% |
Q1 2023 | $76,968,824 | +119.7% | 17,899,726 | +100.8% | 0.00% | +33.3% |
Q4 2022 | $35,029,391 | -25.5% | 8,913,331 | +0.7% | 0.00% | -40.0% |
Q3 2022 | $47,003,000 | -16.3% | 8,851,683 | +3.4% | 0.01% | -16.7% |
Q2 2022 | $56,172,000 | -10.5% | 8,562,941 | +0.1% | 0.01% | +20.0% |
Q1 2022 | $62,763,000 | +3.8% | 8,550,767 | +0.2% | 0.01% | +25.0% |
Q4 2021 | $60,437,000 | -71.7% | 8,536,462 | +0.2% | 0.00% | -76.5% |
Q3 2021 | $213,523,000 | -6.6% | 8,517,087 | +0.3% | 0.02% | -5.6% |
Q2 2021 | $228,516,000 | -5.1% | 8,495,022 | +0.4% | 0.02% | -14.3% |
Q1 2021 | $240,889,000 | +18.3% | 8,464,109 | +17.9% | 0.02% | +16.7% |
Q4 2020 | $203,577,000 | -7.5% | 7,180,864 | -2.6% | 0.02% | -18.2% |
Q3 2020 | $220,063,000 | +52.6% | 7,373,381 | -0.0% | 0.02% | +37.5% |
Q2 2020 | $144,187,000 | – | 7,373,870 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 857,939 | $26,519,000 | 5.98% |
Casdin Capital, LLC | 1,611,214 | $49,803,000 | 2.23% |
Artal Group S.A. | 2,814,191 | $86,987,000 | 2.11% |
HARVARD MANAGEMENT CO INC | 506,273 | $15,649,000 | 0.86% |
Bellevue Group AG | 1,880,000 | $58,111,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 961,215 | $29,711,000 | 0.72% |
FARALLON CAPITAL MANAGEMENT LLC | 2,120,625 | $65,549,000 | 0.45% |
SECTORAL ASSET MANAGEMENT INC | 35,000 | $1,082,000 | 0.09% |
MIRABELLA FINANCIAL SERVICES LLP | 8,886 | $275,000 | 0.04% |
VICTORY CAPITAL MANAGEMENT INC | 866,997 | $26,798,000 | 0.03% |